SG11201600497VA - Novel triazine derivative - Google Patents

Novel triazine derivative

Info

Publication number
SG11201600497VA
SG11201600497VA SG11201600497VA SG11201600497VA SG11201600497VA SG 11201600497V A SG11201600497V A SG 11201600497VA SG 11201600497V A SG11201600497V A SG 11201600497VA SG 11201600497V A SG11201600497V A SG 11201600497VA SG 11201600497V A SG11201600497V A SG 11201600497VA
Authority
SG
Singapore
Prior art keywords
triazine derivative
novel triazine
novel
derivative
triazine
Prior art date
Application number
SG11201600497VA
Inventor
Wataru Kawahata
Tokiko ASAMI
Masaaki Sawa
Yuko ASAMITSU
Takayuki Irie
Takahiro Miyake
Takao Kiyoi
Original Assignee
Carna Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carna Biosciences Inc filed Critical Carna Biosciences Inc
Publication of SG11201600497VA publication Critical patent/SG11201600497VA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
SG11201600497VA 2013-07-26 2014-07-15 Novel triazine derivative SG11201600497VA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2013155331 2013-07-26
JP2013187987 2013-09-11
JP2014073227 2014-03-31
PCT/JP2014/068752 WO2015012149A1 (en) 2013-07-26 2014-07-15 Novel triazine derivative

Publications (1)

Publication Number Publication Date
SG11201600497VA true SG11201600497VA (en) 2016-02-26

Family

ID=52393193

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201600497VA SG11201600497VA (en) 2013-07-26 2014-07-15 Novel triazine derivative

Country Status (15)

Country Link
US (1) US9656995B2 (en)
EP (1) EP3026050B1 (en)
JP (1) JP6156953B2 (en)
KR (1) KR101742550B1 (en)
CN (1) CN105683178B (en)
AU (1) AU2014294225B2 (en)
CA (1) CA2919068C (en)
CR (1) CR20160082A (en)
DK (1) DK3026050T3 (en)
ES (1) ES2699452T3 (en)
IL (1) IL243737B (en)
NO (1) NO20160292A1 (en)
PH (1) PH12016500152A1 (en)
SG (1) SG11201600497VA (en)
WO (1) WO2015012149A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014322239A1 (en) * 2013-09-20 2016-04-14 Carna Biosciences, Inc. Novel triazine derivative
KR102565546B1 (en) 2016-11-25 2023-08-10 카나 바이오사이언스, 인코포레이션 Novel oxoisoquinoline derivatives
EP4101468A4 (en) * 2020-02-05 2024-02-28 Carna Biosciences Inc Anticancer agent composition
WO2022034914A1 (en) * 2020-08-13 2022-02-17 カルナバイオサイエンス株式会社 Readily-soluble solid pharmaceutical preparation and production method for same
US20230405006A1 (en) * 2020-11-13 2023-12-21 Carna Biosciences, Inc. Combination pharmaceutical composition and treatment method

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20110164A1 (en) * 2008-07-02 2011-03-28 Hoffmann La Roche NEW PHENYLpyRAZINONES AS KINASE INHIBITORS
US8299077B2 (en) 2009-03-02 2012-10-30 Roche Palo Alto Llc Inhibitors of Bruton's tyrosine kinase
BR112014003582A2 (en) 2011-08-17 2017-03-14 Hoffmann La Roche bruton tyrosine kinase inhibitors
RU2014126750A (en) * 2011-12-09 2016-01-27 Ф. Хоффманн-Ля Рош Аг BRUTON TYROSINKINASE INHIBITORS
CN104169260A (en) * 2012-03-09 2014-11-26 卡尔那生物科学株式会社 Novel triazone derivative
WO2013161848A1 (en) 2012-04-27 2013-10-31 カルナバイオサイエンス株式会社 Novel 1,2,4-triazine derivative

Also Published As

Publication number Publication date
AU2014294225B2 (en) 2017-02-23
KR20160041946A (en) 2016-04-18
EP3026050A1 (en) 2016-06-01
ES2699452T3 (en) 2019-02-11
IL243737A0 (en) 2016-04-21
EP3026050B1 (en) 2018-11-07
JPWO2015012149A1 (en) 2017-03-02
AU2014294225A1 (en) 2016-03-03
WO2015012149A1 (en) 2015-01-29
IL243737B (en) 2019-09-26
PH12016500152A1 (en) 2016-04-25
CN105683178A (en) 2016-06-15
DK3026050T3 (en) 2019-02-18
CN105683178B (en) 2019-04-12
NO20160292A1 (en) 2016-02-19
CA2919068A1 (en) 2015-01-29
JP6156953B2 (en) 2017-07-05
KR101742550B1 (en) 2017-06-01
US20160168122A1 (en) 2016-06-16
CA2919068C (en) 2018-03-20
US9656995B2 (en) 2017-05-23
CR20160082A (en) 2016-06-08
EP3026050A4 (en) 2016-12-14

Similar Documents

Publication Publication Date Title
HK1222846A1 (en) Substituted benzylpyrazoles
HK1221717A1 (en) Substituted benzylpyrazoles
HK1215795A1 (en) Amatoxin derivatives
EP2824099A4 (en) Novel triazine derivative
SG11201506100XA (en) Pyridazinone-amides derivatives
HRP20171890T1 (en) Substituted imidazopyridazines
ZA201601333B (en) Oxoquinazolinyl-butanamide derivatives
HK1223362A1 (en) Substituted pyrazolo-pyridinamines
SG11201605189YA (en) Imidazopyrazinone derivatives
HK1220972A1 (en) Substituted thiazolopyrimidines
IL246271A0 (en) Substituted piperidinyl-tetrahydroquinolines
IL241293B (en) Novel triazole derivatives
IL243737A0 (en) Novel triazine derivative
IL241859B (en) Novel triazole derivatives
HK1213566A1 (en) Novel tetrazolone derivatives
IL244664A0 (en) Novel triazine derivative
EP3009444A4 (en) Alpha-oxoacyl amino-caprolactam derivative